Milan General Hospital, INC.
Milan General Hospital, INC. was paid $3.54M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99283, emergency room visit (moderate) — 45% of everything it billed.
MILAN, TN 38358
Next to other General Acute Care Hospital providers in Tennessee
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,078 | $467K | |
| 2019 | 14,263 | $526K | |
| 2020 | 12,039 | $534K | |
| 2021 | 12,425 | $532K | |
| 2022 | 15,074 | $702K | |
| 2023 | 13,982 | $457K | |
| 2024incomplete | 9,759 | $322K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 45% | 12,223 | 11,128 | $1.58M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 5,753 | 5,120 | $1.16M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.3% | 1,498 | 1,267 | $296K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.6% | 1,148 | 1,044 | $90K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 2,492 | 2,344 | $66K |
| G0378 | Hospital observation service, per hour | 1.4% | 271 | 209 | $49K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 12,175 | 10,056 | $46K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,286 | 2,996 | $27K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,113 | 3,587 | $26K |
| 80053 | Comprehensive metabolic panel | <1% | 8,383 | 6,909 | $25K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 844 | 755 | $16K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 185 | 172 | $15K |
48 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 973 | $14K |
| 84484 | <1% | 1,137 | $11K | |
| 83690 | <1% | 2,623 | $11K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 756 | $11K |
| 87430 | <1% | 1,669 | $10K | |
| 82150 | <1% | 2,569 | $10K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 235 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,499 | $8K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,602 | $7K |
| 81001 | <1% | 8,360 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,464 | $5K |
| 81025 | <1% | 1,842 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 470 | $4K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 25 | $3K |
| 85730 | <1% | 936 | $3K | |
| 87807 | <1% | 391 | $3K | |
| 43249 | <1% | 15 | $2K | |
| 83880 | <1% | 304 | $2K | |
| 83605 | <1% | 364 | $2K | |
| 85610 | <1% | 1,257 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 46 | $2K |
| 87081 | <1% | 487 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 48 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 12 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 79 | $1K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $1K |
| 87040 | <1% | 261 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 364 | $1K |
| 80305 | <1% | 150 | $912.19 | |
| 85379 | <1% | 127 | $715.73 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 203 | $681.45 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 161 | $659.59 |
| 83735 | <1% | 221 | $426.72 | |
| 80306 | <1% | 84 | $342.86 | |
| 74018 | <1% | 56 | $248.98 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 40 | $164.14 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 27 | $141.12 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $100.28 |
| J3490 | Unclassified drugs | <1% | 16 | $89.97 |
| 86850 | <1% | 211 | $61.39 | |
| 86900 | <1% | 211 | $31.00 | |
| 82962 | <1% | 141 | $29.87 | |
| 86901 | <1% | 211 | $29.51 | |
| 80076 | <1% | 17 | $27.22 | |
| A9270 | Non-covered item or service | 0% | 330 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 203 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 14 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Jackson Madison County General Hospital | Jackson, TN | $46.51M |
| Pathways of Tennessee, INC. | Jackson, TN | $30.54M |
| Dyersburg Health | Dyersburg, TN | $13.19M |
| Jackson-Madison County General Hospital | Jackson, TN | $12.97M |
| Jackson-Madison County General Hospital | Jackson, TN | $7.37M |
| WT Medical Associates | Dyersburg, TN | $5.52M |
| West Tennessee Healthcare Henry County | Paris, TN | $4.47M |
| Therapy & Learning Center INC | Jackson, TN | $4.19M |
| Martin Health | Martin, TN | $3.94M |
| Camden General Hospital, INC. | Camden, TN | $3.46M |
| Pathways of Tennessee, INC. | Jackson, TN | $3.30M |
| Bolivar General Hospital, INC. | Bolivar, TN | $2.36M |
| Martin Health | South Fulton, TN | $1.47M |
| Lift Therapy, INC. | Jackson, TN | $778K |
| Jackson-Madison County General Hospital | Jackson, TN | $449K |
| West Tennessee Healthcare Henry County | Paris, TN | $136K |
| Jackson-Madison County General Hospital | Jackson, TN | $108K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.